TransMedics Group, Inc.
TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditā¦ read more
Healthcare
Medical Devices
6 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$134.77
Price+3.98%
$5.16
1Y
Price
Market Cap
$4.623b
Mid
Price/Earnings 3y Avg5y Avg
27.7x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+23.2%
EBITDA Margin+16.9%
Net Profit Margin+43.1%
Free Cash Flow Margin+23.2%
EBITDA Margin+16.9%
Net Profit Margin+43.1%
Free Cash Flow MarginRevenue
$605.494m
+28.3%
1y CAGR+89.9%
3y CAGR+119.6%
5y CAGREarnings
$190.291m
+158.8%
1y CAGR+143.8%
3y CAGR+112.4%
5y CAGREPS
$4.87
+144.6%
1y CAGR+137.7%
3y CAGR+109.1%
5y CAGRBook Value
$473.100m
$1.068b
Assets$595.273m
Liabilities$469.691m
DebtDebt to Assets
44.0%
3.9x
Debt to EBITDAFree Cash Flow
$133.589m
+249.1%
1y CAGR+24.7%
3y CAGR-1.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company